SecBot SecBot
25-NSE ·Filed Jul 15, 2026

NUVL

Nuvalent, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed4mo ago SEC0001354457-26-000693
Notable filing: 25-NSE
Actionable Insight • Neutral

The delisting is a formality following the completed acquisition. Shareholders who have not yet tendered shares should receive the $124.00 cash consideration. No further trading on Nasdaq is expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK AT ENTRY AT T+5
Entry
$123.96
T+0 close · Jul 15, 2026 · via day close
Latest settled
0.00%
T+5 · $123.96
Vs SPY
+0.98%
α at T+5
Next horizon
T+20
due 3mo ago
  1. T+0 · Jul 15 $123.96entry
  2. T+1 · 4mo ago 0.00%α +0.54% · $123.96
  3. T+5 · 4mo ago 0.00%α +0.98% · $123.96
  4. T+20 · due 3mo ago Pending
  5. T+60 · due 6w ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Nasdaq filed a 25-NSE notification to delist Nuvalent, Inc. shares following the completion of GSK plc's acquisition. The merger closed on July 15, 2026, at $124.00 per share in cash, representing a total equity value of approximately $10.6 billion. This filing is a procedural step finalizing the delisting.

Key Facts

  • Form 25-NSE filed by Nasdaq to remove Nuvalent's Class A Common Stock from listing and registration.
  • Delisting is effective as of July 15, 2026, the same day the GSK acquisition closed.
  • The acquisition was completed at $124.00 per share in cash, with total equity value of approximately $10.6 billion, as reported in the prior 8-K filing.

Financial Impact

Not specified

Risk Factors

  • No residual risk; the deal is closed and the stock is being removed from the exchange.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
35% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0001354457-26-000693
Document: 0001354457-26-000693-index-headers.html0001354457-26-000693
Document: 0001354457-26-000693-index.html0001354457-26-000693
Document: 0001354457-26-000693.txt0001354457-26-000693

Track record

18 reports on NUVL

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +21.01% at T+60 after the Apr 7, 2026 report. 4 of 8 went positive at some point.

Filters
  1. Jul 27, 202616w ago 15-12G Neutral 3/10 No price data
  2. Jul 15, 202617w ago 25-NSE Neutral 3/10 Viewing Entry $123.96 No price data
  3. Jul 15, 202617w ago 8-K Bullish 5/10 Entry $123.96 No price data
  4. Jul 8, 202618w ago Insider Cluster Neutral 3/10 Entry $123.80 No price data
  5. Jul 6, 202619w ago Insider Cluster Neutral 3/10 Entry $123.72 No price data
  6. Jun 11, 202622w ago Insider Cluster Neutral 2/10 Entry $123.25 to $123.90 ▲ +0.53% −1.25% vs SPY
  7. Jun 10, 202622w ago Insider Cluster Neutral 3/10 Entry $123.45 to $123.83 ▲ +0.31% −1.58% vs SPY
  8. Jun 9, 202622w ago 8-K Bullish 8/10 Entry $123.25 to $123.77 ▲ +0.42% −1.02% vs SPY
  9. May 7, 202627w ago 8-K Neutral 4/10 Entry $102.40 to $90.18 ▼ −11.93% −15.07% vs SPY
  10. Apr 29, 202628w ago Insider Cluster Neutral 2/10 Entry $99.10 to $107.38 ▲ +8.36% +2.90% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens in 8h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 15, 2026